cutaneous T-cell lymphoma - Clinical Oncology News

×

ADVERTISEMENT

Register Log in

FDA Updates Opioid Labeling Requirements to Reflect Long-Term Risks

AUGUST 27, 2025

‘Right-Sizing’ Surveillance Intervals for CRC: Considerations for Now and the Future

AUGUST 25, 2025

Access to Oncology Drugs Stymied by Prior Authorization, but Specialty Pharmacists Can Help

AUGUST 22, 2025

cutaneous T-cell lymphoma

Lymphir Approved for Adults With Relapsed or Refractory Cutaneous T-Cell Lymphoma

The FDA has approved denileukin diftitox-cxdl (Lymphir, Citius) for the treatment of relapsed or refractory (R/R) ...

AUGUST 9, 2024

Load more

Check out our new Clinical tab!

We've added an exciting new feature to our website. Click on "Clinical" in the navbar to explore!

The following result is from the NPI Registry Public Search database. You can click on the NPI number to view detailed information and verify its accuracy. If your NPI is not found in this search, you can try searching again using the form below. If you have difficulty finding your NPI number please contact us at web@mcmahonmed.com

First Name

Last Name

OR

Organization/Institution

State

NPI	Name	Organization/ Institution	State	Zip Code	Taxonomy	Credential	Select